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Abstract
Purpose: To report the 27-year statistical data from the Central Eye Bank of Iran (CEBI)
and its activity.
Methods: All CEBI records regarding procured eyes, tissue utilizations, corneal
transplants per capita, and indications for keratoplasty from 1991 to 2017 were analyzed.
Results: In total, 115,743 whole eyes were donated during the 27-year period. Out of
the 114,169 eyes donated between 1994 and 2017, 95,314 eyes were distributed for
transplantation, and 95,057 corneaswere actually transplanted. Themean annual rate of
corneal transplants per capita was 55.10−6 ± 27.10−6. Although penetrating keratoplasty
(PKP, 70%) was the most common technique of corneal transplantation during the
study period, it exhibited a decreasing trend between 2006 and 2017 (P = 0.048). It
was in contrast to Descemet stripping automated endothelial keratoplasty (DSAEK) that
demonstrated an increasing trend during the same period (P<0.001). Keratoconus (KCN,
39.70%) was the most leading indication for keratoplasty over the last three decades
followed by bullous keratopathy (BK, 18.5%), corneal scar and opacities (15.7%), and graft
failure (GF, 7.5%), with an increasing trend for BK, GF, and KCN. A majority of scleral
tissues (83.7%) were utilized for orbital implant protection.
Conclusion: An increasing trend in the number of procured eyes was observed over the
past 27 years in Iran. The most leading indications for corneal transplantation were KCN
and BK. While PKP was the most common keratoplasty technique, DSAEK showed an
increasing trend over the last 12 years.
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Corneal blindness is the third leading cause
of avoidable visual impairment worldwide after
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cataract and glaucoma.[1] Corneal transplantation
via the restoration of visual function improves
both the health status and the quality of life of
patients undergoing keratoplasty.[2] Leading indi-
cations for keratoplasty and implemented surgi-
cal techniques vary from one country to another
depending on their geographic regions, socioeco-
nomic conditions, and adaptation to recent surgical
technological advancements.[3–11] For instance, in
developed countries, bullous keratopathy (BK) and
Fuchs’ endothelial dystrophy (FED) are the leading
indications for keratoplasty, and with the adap-
tation of endothelial keratoplasty (EK) techniques
in these countries, Descemet stripping automated
endothelial keratoplasty (DSAEK) and Descemet
membrane endothelial keratoplasty (DMEK) are the
procedures of choice to selectively replace the
diseased corneal endothelium.[4–8, 11] However, the
leading indications for keratoplasty in developing
countries vary from keratoconus (KCN) in Iran
and Zimbabwe[3, 12, 13] to infectious keratitis and
corneal scarring in China and India.[14, 15] Moreover,
penetrating keratoplasty (PKP) is still the most
common technique for corneal transplantation in
these countries.[3, 12–15]
The Central Eye Bank of Iran (CEBI), the main eye
bank in the center of the national corneal transplan-
tation network over the last 27 years in Iran, has
been processing and distributing the tissues for
corneal and scleral transplantations in accordance
with the international medical standards.[16] Herein,
we report a 27-year statistical data and present a
comprehensive picture of eye banking activity at
the CEBI.
METHODS
After obtaining full approval from the ethics com-
mittee of the Ophthalmic Research Center, affili-
ated with Shahid Beheshti University of Medical
Sciences in Tehran, Iran, a retrospective study was
conducted to review and analyze all the compiled
eye bank data between 1991 and 2017 at the CEBI.
The data compiled included annual and total rates
of procured eyes (1991–2017), ocular tissue utiliza-
tions (2006–2017), corneal transplants per capita
(2006–2017), indications for keratoplasty (1994–
2017), and post-transplantation adverse reactions
(2006–2017). Detailed data regarding postopera-
tive adverse reaction reported to the CEBI were not
available before 2006. All the statistical analyses
were performed using the Statistical Package for
the Social Sciences (SPSS) software version 22
(SPSS, Inc., Chicago, IL, USA). Linear regression
models were utilized to investigate any changing
trend in the variables of interest. P-value < 0.05
was considered statistically significant.
RESULTS
Eye Procurement
During the 27-year period, a total of 115,743 whole
eyes from 58,804 donors were procured. The
annual rates of corneal procurement are illustrated
in Figure 1, showing an increasing rate over the
specified period excluding the last three years
in which the corneal procurement rate showed a
moderate reduction. Considering that detailed data
for 1,574 eyes (from 787 donors) procured between
1991 and 1993 were not available, the analysis of
the majority of the variables was not possible for
this certain time period. Between 1994 and 2017,
a total of 114,169 eyes from 58,017 donors were
procured. Donors’ age ranged from 1 month to 85
years, and 79.4%weremale. Themajority of donors
were in the age range of 21–40 (43.1%) and 41–60
(37.7%) years.
Ocular Tissue Distribution and Utilization
Among the 114,169 eyes procured between 1994
and 2017, 95,314 (83.5%) eyes were distributed
for transplantation purposes, and 95,057 corneas
were transplanted. Small numbers of the procured
eyes that were ineligible for transplantation were
distributed and utilized for research purposes (933,
0.8%). The rate of keratoplasties per year is shown
in Figure 2, illustrating an increasing rate over
the specified period. The distributed corneas were
either in the form of excised corneoscleral discs
(84.6%) maintained in cold storage media such
as Optisol GSTM and Eusol CTM or as whole
globes (17.4%) preserved in cold moist chambers.
Moreover, 7.2% of the whole eyes had been
frozen in –70°, and their corresponding defrosted
corneas were transplanted. Out of the distributed
globes/corneas, 257 (0.3%) cases were returned
non-transplanted to the CEBI due to pre- or intra-
operative technical errors at the time of surgery.
PKP and similar procedures such as tec-
tonic surgery and anterior lamellar keratoplasty
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Figure 1. The annual rates of corneal procurement in Iran. Note the increasing rate of corneal procurement between 1991 and
2017.
accounted for all transplantation techniques used
before 2006with no exact data on each procedure.
Between 2006 and 2017, 71,796 corneas were uti-
lized for keratoplasty. The rate of each transplanta-
tion technique and its corresponding relative trend
over the last 12 years are illustrated in Figure 3.
Over this period, PKP was the most common tech-
nique of corneal transplantation (70%), followed by
anterior lamellar keratoplasty (ALK, 14.24%), DSAEK
(12.41%), and tectonic surgery (3%). A significant
decreasing trend was observed in the rates of
PKP (P = 0.048), ALK (P = 0.024), and tectonic
surgery (P = 0.01), whereas DSAEK demonstrated
an increasing trend (P<0.001) over the last 12 years
[Figure 4]. A small number of corneas were utilized
for keratolimbal allografts (KLALs, 0.21%), glaucoma
shunt coverage (GSC, 0.10%), and DMEK procedure
(0.04%) with an increasing trend since the introduc-
tion of the corresponding procedures (P < 0.001 for
KLAL, P = 0.025 for GSC, and P = 0.023 for DMEK)
[Figure 4]. Almost all the KLALs performed during
the study period utilized donor limbal tissues for
recipients with primary or secondary limbal stem
cell deficiency (LSCD) of variable etiologies, among
which chemical burn injuries and mustard gas
keratopathies predominated.
There were no specified data regarding the uti-
lization of scleral tissues before 2006. From 2006
to 2017, out of the 83,149 procured donated eyes,
2,212 (2.7%) scleral tissues preserved in absolute
alcohol were utilized to provide an additional pro-
tection in the orbital implants following enucleation
(83.7%) and for glaucoma shunt patching (16.3%).
Corneal Transplants Per Capita
The calculated transplantation rate per million
inhabitants in Iran is shown in Figure 5. The annual
numbers of corneal transplants per capita over the
last 24 years ranged from 16.10−6 to 95.10−6 (mean,
55.3.10−6 ± 27.10−6). This increasing rate of corneal
transplants per capita paralleled the increase in the
Iranian population over the specified period.
Indications for Corneal Transplantation
Figures 6 and 7 illustrate the indications for ker-
atoplasty and their corresponding trends between
1994 and 2017, respectively. The donors were pre-
dominantly male (61.2%) and aged from 6months to
96 years. The majority of donors were between 21
and 40 years (38.2%), followed by those between
61 and 80 years (24.1%) and between 41 and 60
years (20.3%). KCN was the main leading indica-
tion for corneal transplantation (39.70%) followed
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Figure 2. The annual rate of keratoplasties in Iran. Note the increasing rate of corneal transplantation between 1994 and 2016.
Figure 3. The mean rate of transplantation procedures and their corresponding relative trends. (A) penetrating keratoplasty
was the most common keratoplasty procedure (70%) over the last 12 years, followed by anterior lamellar keratoplasty (14.24%),
Descemet stripping automated endothelial keratoplasty (12.41%), tectonic (3%), keratolimbal allografts (0.21%), glaucoma shunt
coverage (0.10%), and Descemet membrane endothelial keratoplasty (0.04%). (B) The relative trends of corneal transplantation
techniques between 2006 and 2017 were illustrated.ALK, anterior lamellar keratoplasty; DMEK, Descemet membrane endothelial
keratoplasty; DSAEK, Descemet stripping automated endothelial keratoplasty; KLAL, keratolimbal allografts; GSC, glaucoma shunt
coverage; PKP, penetrating keratoplasty.
by BK (18.5%), corneal scar and opacities (CSO,
15.7%), graft failure (GF, 7.5%), corneal dystrophies
(CD, 5.20%), and active keratitis (AK, 5.20%). The
remaining indications (8.2%) which were consid-
ered “others” included chemical burn injuries,
LSCD, primary glaucoma tube shunt coverage,
exposed glaucoma tube shunts, leaking filtering
bleb, and cases with no specific diagnosis.
A significant increasing trend for BK (P < 0.001),
GF (P < 0.001), and KCN (P = 0.046) was observed;
however, a decreasing trend for CSO (P < 0.001)
and CDs (P = 0.002) over the last 24 years was
observed. AK revealed no significant change in
the trend during the specified period (P = 0.968).
The four most leading CDs were macular corneal
dystrophy (MCD, 2.79%), FED (1.28%), congenital
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Figure 4. Trends of keratoplasty techniques from 2006 to 2017 in Iran. A significant decreasing trend for the rates of penetrating
keratoplasty (P = 0.048), anterior lamellar keratoplasty (P = 0.024), and tectonic surgery (P = 0.01) is observed. A significant
increasing trend of change for the rates of Descemet stripping automated endothelial keratoplasty (P < 0.001), keratolimbal
allografts (P < 0.001), glaucoma shunt coverage (P = 0.025), and Descemet membrane endothelial keratoplasty (P = 0.023) since
their introduction is observed. The regression R2 measures the goodness of fit of the regression line. DMEK, Descemet membrane
endothelial keratoplasty; DSAEK, Descemet stripping automated endothelial keratoplasty; KLAL, keratolimbal allografts; GSC,
glaucoma shunt coverage; PKP, penetrating keratoplasty.
hereditary endothelial dystrophy (CHED, 0.44%),
and granular corneal dystrophy (0.41%). Out of
the 8,950 patients undergoing endothelial kerato-
plasty (8923, DSAEK; 27, DMEK), 78.7% had BK
after cataract surgery, and 21.3% had either FED or
CHED. All the DMEK surgeries utilized pre-stripped
DMEK tissues that were prepared at the CEBI.
Ocular Tissues Used for Glaucoma Shunt
Patching
Between 2006 and 2017, sclera preserved in abso-
lute alcohol was the most frequently used tissue
for glaucoma shunt patching; however, in the last
two years, frozen corneal tissues (in –70°C) that had
unsuitable endothelial quality for keratoplasty were
limitedly used as alternatives to scleral tissues for
patching glaucoma shunts.
Adverse Reactions
Based on the eye bank postoperative reports over
the past 12 years, out of the 71,796 transplants
performed in Iran, adverse reactions were reported
in 63 cases (0.088%). Furthermore, 84.2% of all
transplanted corneas were used for PKP/ALK, and
12.5% were used for EK. The adverse reactions
were reported in 26 (0.04%) and 37 (0.41%) cases
after PKP/ALK and EK, respectively. The most
common adverse reactions after EK were related
to the surgery (n = 22, 0.24%) followed by pri-
mary GF (n = 15, 0.17%). The most frequently
reported adverse reactions after PKP/ALK were
primary GF (n = 13; 0.022%) followed by infectious
keratitis (n = 7, 0.012%) and endophthalmitis (n =
6, 0.01%). The microbiologic pathogens in cases
with transmission of infection were fungi (57%)
and Gram-negative organisms (43%). Microbiologic
pathogens were isolated in 83.3% of endoph-
thalmitis cases, among which Gram-positive organ-
isms (60%) were the most common retrieved
microorganisms.
DISCUSSION
Increased number of corneal transplants in Iran
performed from 1991 to 2017 reflects an expanding
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Figure 5. The annual rates of corneal transplants per capita in Iran. Note an increasing rate of corneal transplants per capita from
1994 to 2017, ranging from 16.10−6 in 1995 to 95.10−6 in 2013.
Figure 6. Mean rates (%) of indications for keratoplasty procedures utilizing corneas provided by the Central Eye Bank of
Iran. Keratoconus has been the most common indication for keratoplasty (39.70%) over the last 24 years, followed by bullous
keratopathy (18.5%), corneal scar and opacities (15.7%), graft failure (7.5%), corneal dystrophies (5.20%), active keratitis (5.20%),
and others (8.2%). AK, active keratitis; BK, bullous keratopathy; CD, corneal dystrophies; CSO, corneal scar and opacities; GF, graft
failure; KCN, keratoconus.
activity of the CEBI and associated cornea sur-
geons. The annual rate of corneal transplants
per capita varied considerably over the last
three decades in Iran. The 27-year statistics
of the CEBI with a well-organized eye bank-
ing infrastructure shows a mean annual rate of
55.3.10−6 corneal transplants per capita, which
is comparable with the annual rates of kerato-
plasty per capita in developed countries such
as France (59.2.10−6), Germany (54.0.10−6), and
the UK (61.3.10−6).[18] This probably reflects the
CEBI’s ability to immediately supply corneal tissues
according to the nation’s demands. Moreover,
it is worthy to know that Iran is one of the
self-sufficient countries among the 148 countries,
with satisfactory access to donated corneas for
transplant, without the need to import corneal
tissues.[18]
154 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 2, APRIL-JUNE 2020
Central Eye Bank Report; Javadi et al
Figure 7. Trends of the leading indications for keratoplasty in Iran over the last 24 years. The trend of change for the rates of bullous
keratopathy (P < 0.001), graft failure (P < 0.001), and keratoconus (P = 0.046) shows a significant increase. A significant decreasing
trend is observed for the rates of corneal scar and opacities (P < 0.001) and corneal dystrophies (P = 0.002). No significant change
of trend is noted for active keratitis (P = 0.968). The regression R2 measures the goodness of fit of the regression line. AK, active
keratitis; BK, bullous keratopathy; CD, corneal dystrophies; CSO, corneal scar and opacities; GF, graft failure; KCN, keratoconus.
Although PKP is the most common keratoplasty
technique in our series, it showed a decreas-
ing trend over the last decade. This is proba-
bly attributed to the increasing rate of DSAEK
performed for BK cases that showed a dramatic
increase during the specified period. These results
are consistent with those reported by the Eye
Bank Association of America (EBAA) in 2016[16] in
which EK remained the top leading keratoplasty
technique in the USA. Similarly, the New Zealand
National Eye Bank reported decreasing trend of
PKP and increasing trend of DSAEK almost at the
same time period.[19]
Although KCN, BK, CSO, GF, CDs, and AK are the
main six indications for corneal graft in our series,
the map of some indications has changed over
the past three decades. Consistent with our prior
published report,[3, 12] indications for keratoplasty
in Iran are characterized by a larger proportion
of KCN, but a lower frequency of AK and CDs.
Moreover, BK, GF, and KCN showed a signifi-
cantly increasing trend over the last 24 years.
Increasing trend of BK could be explained by the
widespread application of phacoemulsification for
cataract surgery in Iran,[20] and the facts that the
surgery was performed even in patients with low
corneal endothelial cell counts [21–23] and by less
experienced surgeons.[24]
GF revealed an increasing trend over the
past three decades, which was consistent with
the increased number of patients undergoing
corneal transplantation and concurrent with the
widespread expansion in the rate of keratoplasties
in Iran. The increasing rate of GF can also be
attributed to the increasing rate of EK techniques
and the decreasing interest in performing ALK
techniques in Iran. GF, defined as a loss of graft
clarity or refractive quality, is mainly observed as
a result of allogeneic immune rejections. However,
nonimmune factors such as glaucoma, endothelial
cell failure, aging, and viral and nonviral infections
may cause GF.[25–27] Although GF was reported
as the most leading indication for keratoplasty in
the UK three decades ago,[28] it did not remain
on the top and declined to the third place in the
later decade, which could be due to the signif-
icant increase in the number of ALK operations
performed.[29]
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KCN in our series ranked the first place among
the leading indications for keratoplasty in Iran and
showed an increasing trend up to 2012. However,
as explained in our prior report,[3] a downward
trend was observed after 2012, which could be due
to the increasing rate of implementation of collagen
corneal cross-linking and intracorneal rings in the
moderate form of KCN. Moreover, the overshad-
owing effect of the increasing trends of BK and
GF over the last decade is considered another
probable explanation.
CSO, in the current study, demonstrated a sig-
nificant decreasing trend over the last 24 years.
Based on our prior reports,[3, 12] CSO was replaced
by BK and declined from the second to the third
place, which can be partially overshadowed by
the increasing trend of BK. However, in some
developing countries, CSO caused by infectious
keratitis and trauma was considered as the most
common indication for keratoplasty.[14, 30, 31] Factors
reducing the incidence of infectious keratitis, such
as public awareness about the importance of early
diagnosis and proper management of infectious
keratitis and preventive measures,[30] may play
significant roles in the decreasing trend of CSO in
Iran.
Different from some Western countries
where FED is the most common indication for
keratoplasty,[16, 32] CDs along with AK ranked the
fifth among the leading indications for keratoplasty
in Iran over the last three decades. Moreover,
consistent with prior studies,[3, 12] FED in our
series was the second common indication for
keratoplasty after MCD among the different types
of CDs. High prevalence of aging population in
Western countries and the increasing awareness
regarding the benefits of the triple procedure
employing EK techniques in cataractous cases with
advanced FED may explain this difference.[8, 33]
Different from our prior published reports in which
no significant change of trend in the number of
procured eyes was shown, our present series
showed a significant decreasing trend over the
last three decades, which can be explained by the
difference in the surveyed time periods. However,
there is a possibility that the decreasing trend
of CDs might have been overshadowed by the
increasing trend of BK and GF. Regarding AK, our
series did not show significant change of trend
over the last three decades; this result is similar to
that of our previous reports.[3, 12] Different from Iran
and several developed countries where AK is not a
common indication for corneal transplantation,[7, 16]
AK is the most common indication for keratoplasty
in the developing countries in Asia. This difference
may be explained by the presence of large
agricultural communities with poor farm and work
safety standards and limited medical services,
leading to higher prevalence of AK in these
developing countries.[9, 34, 35]
Despite it was anticipated that ALK would
replace PKP in corneal pathologies with normal
endothelium,[6] our series revealed a significant
decreasing trend for ALK over the past 12 years;
hence, ALK decreased to its lowest rate in 2017.
This can be explained by the decreasing rate of
transplantation for KCN after 2012. Another pos-
sible reason is that some surgeons may not have
reported ALK in their postoperative reports. To pre-
vent some postoperative complications due to the
transplantation of low-quality grafts (e.g., persistent
epithelial defects, graft edema, and suture-related
complications), some surgeons prefer to report
they perform PKP when actually deep anterior
lamellar keratoplasty is performed to receive a
donor tissue with good quality. This issue needs a
comprehensive strategic planning to address both
the eye bank and the surgeons’ concerns.
Our series demonstrated a significant decreas-
ing trend for tectonic graft for the past 12 years.
Tectonic graft, considered as a challenging and
emergent corneal transplantation, is performed
in corneal pathologies that threaten the globe
integrity such as infectious or noninfectious ker-
atitis. This reinforces the critical role CEBI has in
supplying donor corneas for tectonic purposes to
retain corneal integrity and save the eye in such
patients. The rate of tectonic graft in our series
(3%) was significantly lower than the rate (11.4%)
reported in a six-year analysis of the UK Transplant
Registry.[36] This difference can be explained by the
different time intervals in which the surveys were
performed; the UK Transplant Registry analysis
has been performed between 1999 and 2005[36]
with no updated analysis on the data after 2005,
whereas our survey analyzed the data on trans-
plantation techniques after 2006.
There has been an increasing trend for new
transplantation techniques such as KLAL, GSC
using corneal tissue, and DMEK since their intro-
duction in Iran. Therefore, CEBI has been providing
donated corneal tissues for these techniques of
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transplantation since 2009. In our series, almost
all the KLALs were performed in patients with
LSCD predominantly caused by chemical burns.
Although the management of chemical burn-
induced ocular surface disorders is significantly
challenging, with the recent development in ocular
surface reconstruction and the current use of
translational medicine such as cultured autologous
limbal epithelial transplantation for this purpose in
Iran,[39, 40] a decreasing rate of KLAL is anticipated
over time.
GSC using donor corneal tissue has been imple-
mented for the last two years in Iran, aiming to cover
glaucoma shunt tubes primarily or manage the
exposed tubes and leaking filtering blebs. It was
well demonstrated that early surgical management
of glaucoma tube-related complications reduces
the risk of bleb-associated endophthalmitis.[41] The
use of donor corneal tissues for GCS is not only a
therapeutic option but also provides excellent cos-
metic results.[42] Although the number of GSC surg-
eries was small, it revealed a significant increasing
trend over the last two years. DMEK using CEBI-
prepared pre-stripped tissues was implemented
in a few tertiary eye centers in Iran in 2016 and,
despite having a small proportion, demonstrated
an increasing trend since then. Different from
the USA in which DMEK is more popular than
DSAEK,[18] DMEK has still failed to gain popularity in
Iran. This can be explained by the easier handling
of the DSAEK lenticules as compared to delicate
DMEK tissues. Moreover, the long learning curve
for DMEKmight have limited the use of this surgical
technique by cornea surgeons in Iran. However,
preparation of pre-stripped ready-to-use DMEK
tissues with healthy corneal endothelium and use
of user-friendly DM delivery systems to simplify
the DMEK technique may encourage some cornea
surgeons to substitute DSAEK with DMEK.
Over a 12-year period, the scleral tissues of 2.7%
of the donated whole eyes were processed at the
CEBI and distributed for cosmetic or emergent eye
conditions, predominantly for wrapping the orbital
implants after enucleation. With the emergence
of frozen corneas for covering the glaucoma tube
shunts since 2016, some glaucoma surgeons use
these tissues rather than scleral tissue to achieve
optimum cosmetic results.[42]
In our series, the overall rate of adverse reac-
tions reported to the CEBI (0.088%) was signifi-
cantly low and even less than the reported rate
in the USA (1.2%).[44] Considering that we ana-
lyzed only the officially reported adverse reactions
encountered during early postoperative period,
one of our main drawbacks in this part is probably
the insufficient evidence on the adverse reactions
that were not reported to the CEBI and the lack
of a transplant registry report. In our analysis,
the reported adverse reactions after EK, similar to
the US report,[44] was more frequent than those
after PKP/ALK surgeries. This can be explained
by long learning curves required for DSAEK and
DMEK. Similar to the report by the EBAA between
2007 and 2014,[45] primary GF predominated in our
series over the last 12 years. Different from the
EBAA report in which Candida species was the
most frequent isolated pathogen in post-corneal
graft endophthalmitis,[45] Gram-positive microor-
ganisms predominated in our series. Regarding
infectious keratitis, no significant difference was
found between the rate of fungal keratitis and
keratitis caused by Gram-negative bacteria in our
survey; this result is different from that of the EBAA
report.[45]
The present survey demonstrated a partial
reduction in the rate of corneal procurement from
the CEBI after 2015, which was concurrent with
launching a couple of minor eye banks in Tehran
and Shiraz.[3] Nevertheless, the activity of these
minor eye banks in the national corneal transplan-
tation network was not remarkable, and they had
no roles in preparation of pre-cut DSAEK lenticules
and pre-stripped DMEK tissues.
In conclusion, the CEBI has shown an expanding
activity over the last 27 years, in a way that Iran
has become one of the self-sufficient countries in
the world that does not need to import corneal
tissues. The low rate of reported adverse reactions
indicated a relatively high safety of the graft system
from donor harvesting and preparation in the CEBI
to graft transplantation. With the emergence of
EK techniques over the last decade in Iran, there
has been an increasing trend in the rates of these
surgical procedures and a decreasing trend of PKP.
Despite this observation, PKP remained the most
frequent transplantation procedure over the last 12
years. Although KCN was the most leading indi-
cation for keratoplasty in Iran, BK and GF showed
an increasing trend over the last 24 years. Eye
bank preparation of pre-cut thin lenticules of high
endothelial quality for DSAEK was encouraging for
the cornea surgeons to substitute PKP with DSAEK
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in cases with corneal endothelial diseases. It is
anticipated that providing pre-stripped and pre-
loaded DM tissues with healthy endothelial cells
for DMEK may motivate the surgeons to gradually
substitute DMEK for DSAEK.
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